An auto-immune disease is a condition in which the immune system turns against its own body. Examples of autoimmune diseases include arthritis and psoriasis.
The purpose of this trial is to investigate how quickly and to what extent the newly developed compound is absorbed, broken down, and eliminated by the body. This is compared to a similar compound that is already available on the market. For the similar compound, there is both a US-marketed and an EU-marketed product. The trial consists of two periods. You will randomly be assigned to receive 2 compounds in a random order (1 compound per period). The options are:
- New compound versus an EU-marketed compound.
- New compound versus a US-marketed compound.
- EU-marketed compound versus a US-market compound.
The compounds will be administered as a subcutaneous (under the skin) injection in the abdomen.
Für Deutschland: Bitte beachten Sie: Die Arzneimittelstudien finden im niederländischen Groningen statt. Sie müssen Englisch oder Niederländisch sprechen, verstehen und lesen können, um an einer Studie teilnehmen zu können.